Status:
COMPLETED
Escitalopram Treatment of Night Eating Syndrome
Lead Sponsor:
Duke University
Collaborating Sponsors:
St. Louis University
Conditions:
Night Eating Syndrome
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Night-Eating Syndrome (NES) is an eating disorder characterised by excessive eating at night, sleep disturbance and morning anorexia. This 12-week study examines the effect of escitalopram on symptoms...
Eligibility Criteria
Inclusion
- Age 18-70 years
- Presence of NES
- BMI 25-50
Exclusion
- History of schizophrenia or other psychoses
- History of bipolar disorder, anorexia nervosa, bulimia, binge eating disorder
- Current major depressive disorder
- Suicidal ideation
- Psychotropic drugs in the past month
- Drugs or herbal remedies that significantly affect body weight, current participation in a weight loss program, currently following a specialized diet (e.g., Atkins, Zone, etc)
- Lack of benefit with SSRI treatment for NES
- Serious or unstable medical illness
- Allergy or hypersensitivity to escitalopram
- Pregnant, breast-feeding, or planning pregnancy in the next six months.
Key Trial Info
Start Date :
October 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2011
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00636649
Start Date
October 1 2008
End Date
July 1 2011
Last Update
June 29 2016
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Saint Louis University
St Louis, Missouri, United States, 63103
2
Duke University Medical Center
Durham, North Carolina, United States, 27710